Changes in Beneficial Ownership · 4
Immuneering Corporation
IMRXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1781213596.xml
Filing details
- Report period
- 2026-06-11
- Issuer
- Immuneering Corp
- Issuer CIK
- 0001790340
- Trading symbol
- IMRX
Reporting owner 1
- Name
- HAUSMAN DIANA
- Reporting owner CIK
- 0001563992
- Relationship
- Director
- Address
- 245 MAIN STREET, 2ND FLOOR, CAMBRIDGE, MA, 02142
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | 4.12 | 2026-06-11 | A · Form 4 | 33,350 | A | 0 | [F1] | 2036-06-11 | Class A Common Stock | 33,350 | 33,350 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 11, 2026, and will be fully vested and exercisable on June 11, 2027, or the date of the 2027 annual meeting of stockholders, whichever comes first.↩ 1
Signature 1
- Signed
- /s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
- Date
- 2026-06-11